EUVIMEDEUVIMED entdecken
Open Access

The Impact of Medical Cannabis Laws on Cannabis and Opioid Use Disorder Treatment and Overdose‐Related Health Care Utilization Among Adults With Chronic Noncancer Pain

Emma E McGinty iD, Pradhyumna Wagle, Christie Lee Luo, Nicholas J Seewald, Elizabeth A Stuart, Kayla N Tormohlen

The Milbank Quarterly · 2025

DOI: 10.1111/1468-0009.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Milbank Quarterly, 2025. Verfasst von Emma E McGinty und 5 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medical College and Cornell Health Policy Center. Hauptthemen laut MEDLINE: Medical Marijuana, Chronic Pain, Opioid-Related Disorders, Patient Acceptance of Health Care. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Policy Points Among patients with chronic noncancer pain, state medical cannabis laws did not impact health care use for opioid use disorder. There were no changes in health care use for opioid overdose attributable to medical cannabis laws. Medical cannabis laws do not appear to lead to reductions in adverse opioid‐related outcomes.

Context

State medical cannabis laws, currently in place in 39 states and Washington, DC, provide an avenue for therapeutic use of cannabis to manage chronic noncancer pain stemming from conditions such as arthritis and low back pain. These laws may also influence cannabis and opioid addiction and overdose, for example, if people substitute cannabis in place of opioids to manage pain. No studies, to our knowledge, have examined how state medical cannabis laws influence health care use related to addiction to or overdose from cannabis or opioids among people with chronic noncancer pain.

Methods

We used a difference‐in‐differences design and augmented synthetic control analyses comparing changes in cannabis use disorder (CUD) and opioid use disorder (OUD) treatment and cannabis and opioid overdose‐related health care use before and after medical cannabis law implementation among Medicare beneficiaries with chronic noncancer pain in seven states (Florida, Maryland, Minnesota, New Hampshire, New York, Oklahoma, and Pennsylvania) relative to changes in outcomes over the same period in 17 comparison states (Alabama, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Mississippi, Nebraska, North Carolina, South Carolina, South Dakota, Tennessee, Texas, Virginia, Wisconsin, and Wyoming) without medical cannabis laws.

Findings

State medical cannabis laws had an estimated average effect of less than 0.005 percentage points on the overall proportion of patients receiving any CUD or OUD treatment, less than 0.009 percentage points on the proportion of patients newly initiating CUD or OUD treatment, and less than 0.0005 percentage points on the proportion of patients receiving overdose‐related health care for cannabis or opioid overdoses ( p > 0.05 for all findings).

Conclusions

Our study did not identify effects of state medical cannabis laws on health care use related to CUD or OUD treatment or overdose among Medicare beneficiaries younger than age 65 years with chronic noncancer pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical MarijuanaChronic PainOpioid-Related DisordersPatient Acceptance of Health CareMarijuana AbuseHumansMaleFemaleUnited StatesMiddle AgedAdultAnalgesics, OpioidDrug OverdoseAgedOpiate Overdose

Stichwörter der Autor:innen

addictioncannabis lawcannabis use disorderchronic painopioid use disordersubstance use disorder

Substanzen

Medical MarijuanaAnalgesics, Opioid

Autor:innen und Institutionen

  • Weill Cornell Medical College and Cornell Health Policy Center.
  • Perelman School of Medicine, University of Pennsylvania.
  • Bloomberg School of Public Health, Johns Hopkins University.

ORCID-Profile: Emma E McGinty

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

McGinty, E. E., Wagle, P., Luo, C. L., Seewald, N. J., Stuart, E. A., & Tormohlen, K. N. (2025). The Impact of Medical Cannabis Laws on Cannabis and Opioid Use Disorder Treatment and Overdose‐Related Health Care Utilization Among Adults With Chronic Noncancer Pain. The Milbank Quarterly. https://doi.org/10.1111/1468-0009.70052

Vancouver

McGinty EE, Wagle P, Luo CL, Seewald NJ, Stuart EA, Tormohlen KN. The Impact of Medical Cannabis Laws on Cannabis and Opioid Use Disorder Treatment and Overdose‐Related Health Care Utilization Among Adults With Chronic Noncancer Pain. The Milbank Quarterly. 2025. doi:10.1111/1468-0009.70052

BibTeX
@article{McGinty2025,
  author = {McGinty, Emma E and Wagle, Pradhyumna and Luo, Christie Lee and Seewald, Nicholas J and Stuart, Elizabeth A and Tormohlen, Kayla N},
  title = {The Impact of Medical Cannabis Laws on Cannabis and Opioid Use Disorder Treatment and Overdose‐Related Health Care Utilization Among Adults With Chronic Noncancer Pain},
  journal = {The Milbank Quarterly},
  year = {2025},
  doi = {10.1111/1468-0009.70052}
}
Kostenlos starten →